Trials / Completed
CompletedNCT00319670
A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 25 (planned)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 4 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate patient acceptance of a new MiraLax dose formulation in children currently treated with polyethylene glycol 3350 powder for treatment of constipation.
Detailed description
To evaluate patient acceptance of a new MiraLax dose formulation in children currently treated with polyethylene glycol 3350 powder for treatment of constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MiraLax |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2006-05-01
- First posted
- 2006-04-27
- Last updated
- 2013-02-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00319670. Inclusion in this directory is not an endorsement.